Clinical Trial Update: Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating risk factors in Chinese kidney transplant recipients receiving an MPA-based immunosuppressive regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Kidney Transplant Recipients | Phase 4 | Status: UNKNOWN